Related Experiment Videos
p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation
Lee-Anne Stanton1, Shalev Sabari, Arthur V Sampaio
1CHIR Group in Skeletal Development and Remodeling, Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada N6A 5C1.
The Biochemical Journal
|November 5, 2003
Summary
p38 signaling is crucial for chondrocyte differentiation and endochondral bone growth. Inhibition delays hypertrophic differentiation and reduces key gene expression, highlighting p38
Area of Science:
- Skeletal Biology
- Cell Signaling
- Molecular Biology
Background:
- Longitudinal bone growth relies on chondrocyte proliferation and differentiation in the growth plate.
- Molecular mechanisms controlling chondrocyte hypertrophy are not fully understood.
Purpose of the Study:
- To investigate the role of p38 mitogen-activated protein kinases (MAPK) in chondrocyte hypertrophic differentiation.
- To identify regulators of p38 signaling in chondrogenesis.
Main Methods:
- Established a micromass culture system for reproducible chondrogenic differentiation of mouse limb bud cells.
- Analyzed the expression of p38 kinases, MKK3, and MKK6 during chondrogenesis.
- Utilized pharmacological inhibitors of p38 to assess its functional role.
Main Results:
- All four mammalian p38 MAPK genes and their regulators (MKK3, MKK6) are expressed during chondrogenesis.
- p38 inhibition significantly delayed hypertrophic differentiation, alkaline phosphatase activity, and matrix mineralization.
- Reduced expression of hypertrophic markers (collagen X, MMP13, BSP) was observed upon p38 inhibition.
- Myocyte enhancer factor 2C (MEF2C) was identified as a mediator of p38 function.
Conclusions:
- p38 signaling is essential for normal hypertrophic differentiation of chondrocytes.
- p38 kinase activity regulates the expression of key chondrocyte differentiation markers.
- MEF2C acts as a downstream effector of p38 signaling in chondrocyte gene regulation.